Secondly, assessment of prolactin concentration and hsCRP during the follow-up may provide an indirect insight into the cardiometabolic effects of cabergoline in females with coexistent prolactin excess and thyroid autoimmunity. The gene discussed is PRL; the disease is autoimmune thyroid disease.